{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:39:09Z","timestamp":1792370349588,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pharep.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T04:46:39Z","timestamp":1450759599000},"page":"507-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics, diagnosis and therapeutic strategies for IgG4-related orbital disease"],"prefix":"10.1007","volume":"68","author":[{"given":"Krzysztof","family":"Oles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"S\u0142adzie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bartu\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Leszczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emila","family":"Bojanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Krakowczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2015.11.011_bib0380","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4? A review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0385","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1258\/000456303763046067","article-title":"Immunoglobulins and immunoglobulin subclasses in the elderly","volume":"40","author":"Lock","year":"2003","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pharep.2015.11.011_bib0390","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharep.2015.11.011_bib0395","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2559.2011.04089.x","article-title":"Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions","volume":"60","author":"Go","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pharep.2015.11.011_bib0400","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archophthalmol.2010.45","article-title":"Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder","volume":"128","author":"Kubota","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.pharep.2015.11.011_bib0405","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/jcp.2010.082156","article-title":"Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells","volume":"63","author":"Kubota","year":"2010","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.pharep.2015.11.011_bib0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archophthalmol.2011.16","article-title":"Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease","volume":"129","author":"Plaza","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0415","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","article-title":"IgG4-related disease: historical overview and pathology of hematological disorders","volume":"60","author":"Sato","year":"2010","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.pharep.2015.11.011_bib0420","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0b013e3283418057","article-title":"A clinical overview of IgG4-related systemic disease","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0425","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","article-title":"Treatment approaches to IgG4-related systemic disease","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.pharep.2015.11.011_bib0430","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.annpat.2012.06.008","article-title":"Eosinophilic angiocentric fibrosis: a form of IgG4-related systemic disease?","volume":"32","author":"Benlemlih","year":"2012","journal-title":"Ann Pathol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0435","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10792-011-9451-y","article-title":"Xanthogranulomatous variant of immunoglobulin G4 sclerosing disease presenting as ptosis, proptosis and eyelid skin plaques","volume":"31","author":"Mudhar","year":"2011","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0440","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/09273948.2010.490629","article-title":"Orbital necrobiotic xanthogranuloma associated with systemic IgG4 disease","volume":"18","author":"Singh","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"25","key":"10.1016\/j.pharep.2015.11.011_bib0445","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.14.3948","article-title":"IgG4-related sclerosing disease","volume":"14","author":"Kamisawa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0450","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2169\/internalmedicine.46.0183","article-title":"Renal lesions in IgG4-related systemic disease","volume":"46","author":"Saeki","year":"2007","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.pharep.2015.11.011_bib0455","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/keh447","article-title":"Clinical and pathological differences between Mikulicz's disease and Sj\u00f6gren's syndrome","volume":"44","author":"Yamamoto","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.pharep.2015.11.011_bib0460","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/BOR.0b013e32834ddb4a","article-title":"The latest on IgG4-RD: a rapidly emerging disease","volume":"24","author":"Carruthers","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.pharep.2015.11.011_bib0465","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.pharep.2015.11.011_bib0470","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.semdp.2012.08.001","article-title":"The pathology of IgG4-related disease: critical issues and challenges","volume":"29","author":"Deshpande","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.pharep.2015.11.011_bib0475","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3349\/ymj.2012.53.1.15","article-title":"IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease","volume":"53","author":"Divatia","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.pharep.2015.11.011_bib0480","first-page":"1","article-title":"IgG4-related orbital disease: a meta-analysis and review","volume":"11","author":"Andrew","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.pharep.2015.11.011_bib0485","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pharep.2015.11.011_bib0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3960\/jslrt.51.13","article-title":"IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century","volume":"51","author":"Masaki","year":"2011","journal-title":"J Clin Exp Hematop"},{"issue":"14","key":"10.1016\/j.pharep.2015.11.011_bib0495","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2169\/internalmedicine.49.3532","article-title":"Analysis of serum IgG subclasses in Churg\u2013Strauss syndrome \u2013 the meaning of elevated serum levels of IgG4","volume":"49","author":"Yamamoto","year":"2010","journal-title":"Intern Med"},{"issue":"8","key":"10.1016\/j.pharep.2015.11.011_bib0500","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","article-title":"Ocular adnexal lymphoma associated with IgG4 chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease","volume":"32","author":"Cheuk","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.pharep.2015.11.011_bib0505","first-page":"818","article-title":"Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder and Graves ophthalmopathy","volume":"129","author":"Kubota","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.pharep.2015.11.011_bib0510","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00535-006-1908-9","article-title":"Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis","volume":"41","author":"Hamano","year":"2006","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.pharep.2015.11.011_bib0515","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/01676830.2011.616618","article-title":"A case of orbital involvement in IgG4-related disease","volume":"31","author":"Teichman","year":"2012","journal-title":"Orbit"},{"issue":"8","key":"10.1016\/j.pharep.2015.11.011_bib0520","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.3174\/ajnr.A2256","article-title":"IgG4-related inflammatory pseudotumor of the trigeminal nerve: another component of IgG4-related sclerosing disease?","volume":"32","author":"Katsura","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3174\/ajnr.A2495","article-title":"Immunoglobulin G4-related disease mimicking invasive tumor in the nasal cavity and paranasal sinus","volume":"33","author":"Sasaki","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"8","key":"10.1016\/j.pharep.2015.11.011_bib0530","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2008.089169","article-title":"Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders","volume":"68","author":"Masaki","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.pharep.2015.11.011_bib0535","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3899\/jrheum.091153","article-title":"IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights","volume":"37","author":"Masaki","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.pharep.2015.11.011_bib0540","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/s10165-011-0508-6","article-title":"A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details","volume":"22","author":"Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"12","key":"10.1016\/j.pharep.2015.11.011_bib0550","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"21","key":"10.1016\/j.pharep.2015.11.011_bib0555","first-page":"1043","article-title":"Immunoglobulin G4-related disease (IgG4-RD) in the orbit: mucosa-associated lymphoid tissue (MALT)-type lymphomas","volume":"10","author":"Ole\u015b","year":"2015","journal-title":"Med Sci Monit"},{"issue":"2","key":"10.1016\/j.pharep.2015.11.011_bib0560","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5114\/fn.2015.52407","article-title":"IgG4-related inflammatory orbital pseudotumors \u2013 a retrospective case series","volume":"53","author":"Ole\u015b","year":"2015","journal-title":"Folia Neuropathol"},{"issue":"18","key":"10.1016\/j.pharep.2015.11.011_bib0565","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00535-007-2043-y","article-title":"Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002","volume":"42","author":"Nishimori","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0570","first-page":"14","article-title":"Cutoff values of serum IgG4 and histopathological IgG4 plasma cells for diagnosis of patients with IgG4-related disease","volume":"5808","author":"Masaki","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"4","key":"10.1016\/j.pharep.2015.11.011_bib0575","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.semdp.2012.07.008","article-title":"IgG4-related disease in the head and neck","volume":"29","author":"Ferry","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"10","key":"10.1016\/j.pharep.2015.11.011_bib0580","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.eye.6702383","article-title":"Orbital inflammatory disease: a diagnostic and therapeutic challenge","volume":"20","author":"Gordon","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharep.2015.11.011_bib0585","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/PAS.0b013e3181a5a207","article-title":"Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study","volume":"33","author":"Yamamoto","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"June (3)","key":"10.1016\/j.pharep.2015.11.011_bib0590","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11882-012-0319-7","article-title":"Ocular myositis","volume":"13","author":"Fraser","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.pharep.2015.11.011_bib0595","doi-asserted-by":"crossref","first-page":"635473","DOI":"10.1155\/2012\/635473","article-title":"Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders","volume":"2012","author":"Takahira","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"2","key":"10.1016\/j.pharep.2015.11.011_bib0600","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3960\/jslrt.51.125","article-title":"Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"51","author":"Matsuo","year":"2011","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.pharep.2015.11.011_bib0605","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1440-1789.2011.01227.x","article-title":"Vertebral basilar system dolichoectasia with marked infiltration of IgG4-containing plasma cells: a manifestation of IgG4-related disease?","volume":"32","author":"Toyoshima","year":"2012","journal-title":"Neuropathology"},{"issue":"5","key":"10.1016\/j.pharep.2015.11.011_bib0610","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0b013e3181ee63ce","article-title":"IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity","volume":"17","author":"Cheuk","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"64","key":"10.1016\/j.pharep.2015.11.011_bib0615","first-page":"35","article-title":"Orbital mass as manifestation of Wegener's granulomatosis: an ophthalmologic diagnostic approach","volume":"29, 1","author":"Bijlsma","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.pharep.2015.11.011_bib0620","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.27435","article-title":"Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease","volume":"62","author":"Khosroshahi","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.pharep.2015.11.011_bib0625","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.pharep.2015.11.011_bib0630","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","article-title":"IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0635","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","article-title":"Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4","volume":"33","author":"Zen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.pharep.2015.11.011_bib0640","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","article-title":"Ocular adnexal IgG4-related disease has uniform clinicopathology","volume":"58","author":"Sato","year":"2008","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.pharep.2015.11.011_bib0645","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1309\/AJCPE1G8DRHXRPIH","article-title":"IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma","volume":"137","author":"Karamchandani","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0650","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jcp.2010.085613","article-title":"Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders","volume":"64","author":"Strehl","year":"2011","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.pharep.2015.11.011_bib0655","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/modpathol.2009.94","article-title":"IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material","volume":"22","author":"Deshpande","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0660","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gut.52.5.683","article-title":"Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis","volume":"52","author":"Kamisawa","year":"2003","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.pharep.2015.11.011_bib0665","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease","volume":"22","author":"Sato","year":"2009","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.pharep.2015.11.011_bib0670","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/PAS.0b013e3181ac43b6","article-title":"Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology","volume":"33","author":"Shrestha","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.pharep.2015.11.011_bib0675","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3960\/jslrt.52.51","article-title":"Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease","volume":"52","author":"Sato","year":"2012","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.pharep.2015.11.011_bib0680","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3960\/jslrt.50.27","article-title":"Clonal analysis of bilateral, recurrent, or systemically multifocal ocular adnexal lymphoma","volume":"50","author":"Matsuo","year":"2010","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.pharep.2015.11.011_bib0685","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3960\/jslrt.50.129","article-title":"Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement","volume":"50","author":"Matsuo","year":"2010","journal-title":"J Clin Exp Hematop"},{"issue":"9","key":"10.1016\/j.pharep.2015.11.011_bib0690","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RLU.0b013e3181b06c03","article-title":"F-18 FDG PET\/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas","volume":"34","author":"Suga","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.pharep.2015.11.011_bib0695","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.pas.0000213445.08902.11","article-title":"Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related sclerosing disease?","volume":"31","author":"Cheuk","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0700","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/BOR.0b013e3283413469","article-title":"Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis","volume":"23","author":"Sah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.pharep.2015.11.011_bib0705","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/eye.2012.4","article-title":"Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing \u2018idiopathic\u2019 from the nomenclature?","volume":"26","author":"Lindfield","year":"2012","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.pharep.2015.11.011_bib0710","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/eye.2012.147","article-title":"Rituximab in IgG4-related inflammatory disease of the orbit and ocular adnexae","volume":"26","author":"Lindfield","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.pharep.2015.11.011_bib0715","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pharep.2015.11.011_bib0720","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2011.07.004","article-title":"IgG4-related systemic disease as a cause of \u2018idiopathic\u2019 orbital inflammation including orbital myositis, and trigeminal nerve involvement","volume":"57","author":"Wallace","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0725","doi-asserted-by":"crossref","DOI":"10.2217\/fon.15.191","article-title":"Bortezomib in the treatment of mantle cell lymphoma","author":"Robak","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.pharep.2015.11.011_bib0730","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3816\/CLML.2010.n.034","article-title":"Treatment with bortezomib of a patient having hyper IgG4 disease","volume":"10","author":"Khan","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"5","key":"10.1016\/j.pharep.2015.11.011_bib0735","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/APO.0000000000000077","article-title":"Orbital immunoglobulin G4-related disease: a systematic review","volume":"3","author":"Mulay","year":"2014","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"9","key":"10.1016\/j.pharep.2015.11.011_bib0740","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3109\/00365521.2011.584896","article-title":"Therapeutic management and clinical outcome of autoimmune pancreatitis","volume":"46","author":"Pezzilli","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"December (6)","key":"10.1016\/j.pharep.2015.11.011_bib0745","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/09273948.2012.714045","article-title":"Infliximab therapy for a severe case of IgG4-related ocular adnexal disorder recalcitrant to corticosteroid treatment","volume":"20","author":"Balaskas","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.pharep.2015.11.011_bib0750","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/232960","article-title":"Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice","volume":"2012","author":"Ryu","year":"2012","journal-title":"Int J Rheumatol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015003680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:21Z","timestamp":1752611781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.11.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1734114015003680"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.11.011","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics, diagnosis and therapeutic strategies for IgG4-related orbital disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}